254 related articles for article (PubMed ID: 8641483)
1. RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium.
Stewart EA; Austin DJ; Jain P; Penglase MD; Nowak RA
Fertil Steril; 1996 Jun; 65(6):1119-24. PubMed ID: 8641483
[TBL] [Abstract][Full Text] [Related]
2. Onapristone suppresses prolactin production in explant cultures of leiomyoma.
Austin DJ; Nowak RA; Stewart EA
Gynecol Obstet Invest; 1999; 47(4):268-71. PubMed ID: 10352391
[TBL] [Abstract][Full Text] [Related]
3. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
4. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
5. Endometrial effects of long-term low-dose administration of RU486.
Murphy AA; Kettel LM; Morales AJ; Roberts V; Parmley T; Yen SS
Fertil Steril; 1995 Apr; 63(4):761-6. PubMed ID: 7890059
[TBL] [Abstract][Full Text] [Related]
6. The myometrium of postmenopausal women produces prolactin in response to human chorionic gonadotropin and alpha-subunit in vitro.
Stewart EA; Jain P; Penglase MD; Friedman AJ; Nowak RA
Fertil Steril; 1995 Nov; 64(5):972-6. PubMed ID: 7589644
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein hormones and their common alpha-subunit stimulate prolactin production by explant cultures of human leiomyoma and myometrium.
Stewart EA; Rein MS; Friedman AJ; Zuchowski L; Nowak RA
Am J Obstet Gynecol; 1994 Feb; 170(2):677-83. PubMed ID: 7509571
[TBL] [Abstract][Full Text] [Related]
8. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells.
Wang Y; Feng G; Wang J; Zhou Y; Liu Y; Shi Y; Zhu Y; Lin W; Xu Y; Li Z
Hum Reprod; 2015 Jan; 30(1):61-70. PubMed ID: 25398968
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium.
Sharara FI; Nieman LK
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):814-9. PubMed ID: 7573249
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
Maleeva A; Milkov V
Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone.
Matsuo H; Maruo T; Samoto T
J Clin Endocrinol Metab; 1997 Jan; 82(1):293-9. PubMed ID: 8989276
[TBL] [Abstract][Full Text] [Related]
13. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
14. p53 Tumor suppressor protein content in human uterine leiomyomas and its down-regulation by 17 beta-estradiol.
Gao Z; Matsuo H; Nakago S; Kurachi O; Maruo T
J Clin Endocrinol Metab; 2002 Aug; 87(8):3915-20. PubMed ID: 12161533
[TBL] [Abstract][Full Text] [Related]
15. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
[TBL] [Abstract][Full Text] [Related]
16. Prolactin is Expressed in Uterine Leiomyomas and Promotes Signaling and Fibrosis in Myometrial Cells.
DiMauro A; Seger C; Minor B; Amitrano AM; Okeke I; Taya M; Rackow AR; Kumar D; Kottman RM; Bhagavath B; Hammes SR
Reprod Sci; 2022 Sep; 29(9):2525-2535. PubMed ID: 34724171
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.
Shimomura Y; Matsuo H; Samoto T; Maruo T
J Clin Endocrinol Metab; 1998 Jun; 83(6):2192-8. PubMed ID: 9626159
[TBL] [Abstract][Full Text] [Related]
18. Decreased prolactin secretion by explant cultures of fibroids from women treated with a gonadotropin-releasing hormone agonist.
Rein MS; Friedman AJ; Heffner LJ
J Clin Endocrinol Metab; 1990 Jun; 70(6):1554-8. PubMed ID: 2112150
[TBL] [Abstract][Full Text] [Related]
19. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle.
Stewart EA; Friedman AJ; Peck K; Nowak RA
J Clin Endocrinol Metab; 1994 Sep; 79(3):900-6. PubMed ID: 8077380
[TBL] [Abstract][Full Text] [Related]
20. Prolactin production from proliferative phase leiomyoma.
Daly DC; Walters CA; Prior JC; Kuslis ST; Chapitis J; Andreoli J; Riddick DH
Am J Obstet Gynecol; 1984 Apr; 148(8):1059-63. PubMed ID: 6711639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
